Form D · Other Health Care
Vinci Pharmaceuticals, Inc.
Avon By The Sea, NJ · CIK 0001785495
Offering snapshot reported Jan 26, 2026 · SEC filing
- Reported sold
- $20.2M Offering amount: $25.3M
- Investors reported
- 53 Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Jan 2, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 26, 2026 | Initial | $20,218,331 | No comparison | 53 | SEC filing |
| Aug 15, 2019 | Initial | $1,000,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- $117K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-571185
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| SUPERVISION PARTNERS LLC | 300528 | |
| THIRD SEVEN CAPITAL, LLC | 160209 |
Source: Form D, filed Jan 26, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Neil Austrian Jr. | Director |
| Philip Gioia | Director, Executive |
| Sarah Hassan | Director |
| Sigurd Kirk | Director |
| Richard Lindstrom | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
12 Washington Avenue
Avon By The Sea, NJ, 07717
Avon By The Sea, NJ, 07717